We analyzed the Variant Caller Files generated by bioinformatics analyses and we retained all non-synonymous and splice variants found at 1% with at least 50 mutated reads both for KRAS/NRAS-positive (Supplementary Table 4A) and negative (Supplementary Table 4B) colon and lung cancer biopsies. Here, NRAS is linked to lung carcinoma.